Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis

Kurzanzeige
dc.contributor.authorLingampally, Arun
dc.contributor.authorJones, Matthew R.
dc.contributor.authorBagari, Shirisha
dc.contributor.authorChen, Chengshui
dc.contributor.authorRivetti, Stefano
dc.contributor.authorBellusci, Saverio
dc.date.accessioned2022-08-23T07:48:52Z
dc.date.available2022-08-23T07:48:52Z
dc.date.issued2020
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/6732
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-6183
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddcddc:610
dc.titleUse of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.articlenumber569865
local.source.epage9
local.source.journaltitleFrontiers in Bioengineering and Biotechnology
local.source.spage1
local.source.urihttps://doi.org/10.3389/fbioe.2020.569865
local.source.volume8

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Vorschaubild
Name:
10.3389_fbioe.2020.569865.pdf
Größe:
1.94 MB
Format:
Adobe Portable Document Format
Herunterladen

Sammlungen

Publikationen im Open Access gefördert durch die UB